News
10 Health Care Stocks Whale Activity In Today's Session
29 Mar 24
Options
RBC Capital Initiates Coverage On Fulcrum Therapeutics with Outperform Rating, Announces Price Target of $14
13 Mar 24
News, Price Target, Initiation, Analyst Ratings
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
6 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
6 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
28 Feb 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on Fulcrum Therapeutics, Raises Price Target to $17
28 Feb 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on Fulcrum Therapeutics, Raises Price Target to $15
28 Feb 24
News, Price Target, Analyst Ratings
Fulcrum Therapeutics Q4 GAAP EPS $(0.40) Beats $(0.43) Estimate, Sales $871.00K Beat $460.00K Estimate; Cash Balance Of $236.2M Expected To Provide Cash Runway Into 2026
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Earnings Preview: Fulcrum Therapeutics
26 Feb 24
Earnings
Goldman Sachs Maintains Neutral on Fulcrum Therapeutics, Raises Price Target to $6
26 Jan 24
News, Price Target, Analyst Ratings
Goldman Sachs Maintains Neutral on Fulcrum Therapeutics, Raises Price Target to $6
25 Jan 24
News, Price Target, Analyst Ratings
Press releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22 Mar 24
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8 Mar 24
Markets, Press Releases
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023
27 Feb 24
Earnings, Press Releases
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8:00 a.m. ET
20 Feb 24
Press Releases